Genetic Variants of Abo Blood Group and Coronary Artery Disease
Main Article Content
Abstract
Background: The ABO gene encodes for the blood group antigens which are expressed on the surface of RBCs, platelets and the vascular endothelium. Several recent studies and GWASs have identified ABO as a locus for thrombosis, myocardial infarction, and multiple cardiovascular risk biomarkers.
Objectives: The objective of the study was to determine the association of genetic variants in the ABO gene with coronary artery disease (CAD).
Study design-setting-patients: A total of 500 subjects including 250 angiographically verified CAD patients’ age and gender matched with 250 angiographically verified controls were recruited for the study. Genotyping of variants A2 (deletion of C; rs918130198), B (G803C;rs8176747), O1 (deletion of G; rs8176719), O2 (G802A;rs1286157771) and A1 (wild type) alleles were performed by allele specific PCR and lipid profile, hsCRP & sICAM1 levels were estimated for all subjects.
Outcome measures: This study will help understand the influence of genetic variations in the ABO genotypes on the risk of CAD amongst Indians.
Findings & interpretation: Among the blood group alleles, O1 (Cases-32%; Controls-50%; p= 0.009) and the B allele (Cases-34%; Controls-19%; p=0.01) were significantly associated with CAD while others (A1, A2 and O2 alleles) were insignificant. The O1 allele suggested an atheroprotective role while the B variant was atherogenic. Genotypically, the BB genotype was more prone to develop CAD with a 5 fold increased risk while the O1O1 genotype was at least risk protecting the individual by 2 folds. The distributions of remaining genotypic combinations of blood groups were found similar in both the groups.
Conclusion: These findings suggest the B blood group individuals especially BB genotypes to be at higher risk for CAD while the O1 allele playing an atheroprotective role.
Downloads
Article Details
Copyright (c) 2020 Chawla PK, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.
We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.
Peertechz accomplice with- [CC BY 4.0]
Explanation
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:
|
License Name |
Permission to read and download |
Permission to display in a repository |
Permission to translate |
Commercial uses of manuscript |
|
CC BY 4.0 |
Yes |
Yes |
Yes |
Yes |
The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.
Tan ST, Scott W, Panoulas V, Sehmi J, Zhang W, et al. (2014) Coronary heart disease in Indian Asians. Glob Cardiol Sci Pract 4: 13-23. Link: https://bit.ly/2LerVdq
Trenkwalder T, Kessler T, Schunkert H, Erdmann J (2015) Genetics of coronary artery disease: Short people at risk? Expert Rev Cardiovasc Ther 13: 1169-1172. Link: https://bit.ly/2zmus2y
Holmes MV, Shah SH, Angelakopoulou A, Khan T, Swerdlow D, et al. (2009) Complex disease genetics: present and future translational applications. Genome Med 1: 104. Link: https://bit.ly/2WCsAeb
Mannarino E, Pirro M (2008) Molecular biology of atherosclerosis. Clin Cases Miner Bone Metab 5: 57-62. Link: https://bit.ly/2L7bxf0
Reilly M, Li M, He J, Ferguson J (2011) Novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association. Lancet 377: 383-392.
Adamo PJD (2015) Diet , Disease and the ABO Blood Groups. Link: https://bit.ly/2WcmiTq
Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, et al. (2011) Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 478: 103-109. Link: https://bit.ly/2Lc9giw
Allan TM, Dawson AA (1968) ABO Blood Groups and Ischaemic Heart Disease in Men. Br Heart J 30: 377-382. Link: https://bit.ly/3bbiIgR
Liumbruno GM, Franchini M (2013) Beyond immunohaematology: The role of the ABO blood group in human diseases. Blood Transfus 11: 491-499. Link: https://bit.ly/2SJrKLG
Patnaik SK, Helmberg W, Blumenfeld OO (2012) BGMUT: NCBI dbRBC database of allelic variations of genes encoding antigens of blood group systems. Nucleic Acids Res 40: D1023–D1029. Link: https://bit.ly/2WAbEFf
Etemadi A, Kamangar F, Islami F, Poustchi H, Pourshams A, et al. (2015) Mortality and cancer in relation to ABO blood group phenotypes in the Golestan Cohort Study. BMC Med 13: 8. Link: https://bit.ly/3bcdYY3
Zhang H, Mooney CJ, Reilly MP (2012) ABO Blood Groups and Cardiovascular Diseases. Int J Vasc Med 2012: 641917. Link: https://bit.ly/2LdeFGd
Barbalic M, Dupuis J, Dehghan A, Bis JC, Hoogeveen RC, et al. (2010) Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum Mol Genet 19: 1863-1872. Link: https://bit.ly/3bbOQkh
Paterson AD, Lopes-Virella MF, Waggott D, Boright AP, Hosseini SM, et al. (2009) Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin. Arterioscler Thromb Vasc Biol 29: 1958-1967. Link: https://bit.ly/2YR6BCO
Karakas M, Baumert J, Kleber ME, Thorand B, Dallmeier D, et al. (2012) A Variant in the Abo Gene Explains the Variation in Soluble E-Selectin Levels-Results from Dense Genotyping in Two Independent Populations. PLoS One 7: e51441. Link: https://bit.ly/3dmIOi8
Dokken BB (2008) The Pathophysiology of Cardiovascular Disease and Diabetes : Beyond Blood Pressure and Lipids. Diabetes Spectr 21: 160-165. Link: https://bit.ly/2L7WZf2
Mudau M, Genis A, Lochner A, Strijdom H (2012) Endothelial dysfunction: the early predictor of atherosclerosis. Cardiovasc J Afr 23: 222-231. Link: https://bit.ly/3chl2Ed
Willerson JT, Ridker PM (2004) Inflammation as a cardiovascular risk factor. Circulation 109: II2-10. Link: https://bit.ly/2yGCGCT
Jukic I, Bingulac-Popovic J, Dogic V, Babic I, Culej J, et al. (2009) ABO blood groups and genetic risk factors for thrombosis in Croatian population. Croat Med J 50: 550-558. Link: https://bit.ly/3dq6It7
Carpeggiani C, Coceani M, Landi P, Michelassi C, L'abbate A (2010) ABO blood group alleles: A risk factor for coronary artery disease. An angiographic study. Atherosclerosis 211: 461-466. Link: https://bit.ly/2AdouBT
Sharif S, Anwar N, Farasat T, Naz S (2014) ABO blood group frequency in Ischemic heart disease patients in Pakistani population. Pak J Med Sci 30: 2013–2015. Link: https://bit.ly/3cfNWEB
Thakur S, Gupta S, Parchwani H, Shah V, Yadav V (2011) Hs-CRP - A Potential Marker for Coronary Heart Disease. Indian J Fundam Appl Life Sci 1: 1-4. Link: https://bit.ly/2L7It79
Naitza S, Porcu E, Steri M, Taub DD, Mulas A, et al. (2012) A genome-wide association scan on the levels of markers of inflammation in sardinians reveals associations that underpin its complex regulation. PLoS Genet 8: e1002480. Link: https://bit.ly/2La3E8H
Chen Z, Yang S, Xu H, Li J (2016) ABO blood group system and the coronary artery disease: an updated systematic review and meta-analysis. Sci Rep 6. Link: https://bit.ly/3cgNUwv